Evnin Luke's Form 4 filing
Werewolf Therapeutics, Inc. (HOWL) · filed Jan 15, 2026
- Accession no.
- 0001134657-26-000005
- Filed
- Jan 15, 2026
- Trade date
- Jan 13-15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $61.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evnin LukeCIK 0001134657 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | Common Stock | SSaleDisposed | −43,198 | $0.55 | −$23,758.9 | 2,266,671 | Indirect | |
| Jan 14, 2026 | Common Stock | SSaleDisposed | −30,616 | $0.57 | −$17,451.12 | 2,236,055 | Indirect | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −37,413 | $0.55 | −$20,577.15 | 2,198,642 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.